HDFC Pharma And Healthcare Fund Regular - Growth
HDFC Pharma And Healthcare Fund Regular - Growth: Mutual Fund Overview
HDFC Pharma And Healthcare Fund Regular - Growth is an Sectoral-Pharma mutual fund with over 2.44 years of performance history. The scheme manages an AUM of ₹2030.8 Cr and has a NAV of ₹17.622. It is rated 'Not Rated' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 16.86%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 16.86% at 12 Mar 2026 08:44 PM
Fund Details
NAV 17.622
Sub-Type Sectoral-Pharma
Rating Not Rated
Min. SIP Amount ₹100.0
Fund Age(Year) 2.44
Fund Size(in Crores) 2030.8
Fund Performance
1 Month 1.09%
3 Month 2.03%
6 Month 1.25%
1 Year 16.86%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.22%) Market Cap Small Cap 30.45 Large Cap 26.97 Mid Cap 40.8 Top Sectors Healthcare 98.22 Top Holding Sun Pharmaceutical Industries 9.81 Thyrocare Technologies 1.39 Glenmark Pharmaceuticals 6.62 Krishna Institute 3.61 Divi's Laboratories 8.38 Ipca Laboratories 4.8 Wockhardt 1.73 Global Health 1.84 Laurus Labs 2.91 Acutaas Chemicals 3.6 Max Healthcare Institute 6.36 Shilpa Medicare 1.68 Rubicon Research 1.22 Bajaj Healthcare 0.92 Torrent Pharmaceuticals 2.34 Sai Life Sciences 2.09 Anthem Biosciences 4.46 Alkem Laboratories 6.21 Dr. Lal Pathlabs 1.63 Jubilant Pharmova 1.35 Aster DM Healthcare 5.42 Laxmi Dental 0.61 Lupin 6.44 Vijaya Diagnostic Centre 2.3 Fortis Healthcare 4.02 Gland Pharma 1.12 Eris Lifesciences 2.28 CORONA Remedies 0.55 Metropolis Healthcare 2.53
Debt & Others (1.78%) Sector Allocation Repo 1.88 Net Payables -0.1 Debt Credit Ratings Debt Category Others 1.78
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.09%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Dhruv Muchhal
Education Mr. Dhruv has done B.Com, CA and CFA
Experience Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Nikhil Mathur
Education Mr. Mathur has done B.Tech and PGDM in Finance
Experience Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 11
Date of Incorporation 2023-10-04
Total AUM 952319.77
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
